Teva Pharmaceutical Industries (TEVA) Return on Invested Capital Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 111.53 Bn | 109.67 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.57 Bn | 35.83 Bn | 1.97 Bn |
| 3 | Zoetis | 33.84 Bn | 31.90 Bn | 1.62 Bn |
| 4 | United Therapeutics | 24.62 Bn | 22.47 Bn | 648.10 Mn |
| 5 | Aurora Cannabis | 17.89 Bn | 17.81 Bn | 33.43 Mn |
| 6 | Neurocrine Biosciences | 15.75 Bn | 14.43 Bn | 800.70 Mn |
| 7 | Regencell Bioscience Holdings | 13.55 Bn | 13.55 Bn | - |
| 8 | Elanco Animal Health | 10.61 Bn | 10.18 Bn | 785.00 Mn |
| 9 | HUTCHMED (China) | 10.36 Bn | 9.02 Bn | - |
| 10 | Alkermes | 6.14 Bn | 5.63 Bn | -116.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 1.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 1.00 |
| Dec 31, 2022 | 1.00 |
| Sep 30, 2022 | 4.00 |
| Jun 30, 2022 | 7.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Dec 31, 2019 | 0.00 |
| Mar 31, 2019 | 0.00 |
| Jun 30, 2018 | -1.00 |
| Mar 31, 2018 | -1.00 |
| Dec 31, 2017 | -2.00 |
| Sep 30, 2017 | -4.00 |
| Jun 30, 2017 | -7.00 |
| Mar 31, 2017 | 0.00 |
| Dec 31, 2016 | 0.00 |
| Sep 30, 2016 | 0.00 |
| Jun 30, 2016 | 0.00 |
| Dec 31, 2015 | 0.00 |
| Dec 31, 2014 | 0.00 |
| Mar 31, 2014 | 0.00 |